EcoDrugPlus

Mast/stem Cell Growth Factor Receptor Kita

Ensembl ID : ENSELUG00000009687
Gene Symbol: LOC105020866
3 Cross references
205 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSELUG00000000174
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSELUG00000000542
Gene Symbol: MMP9
1 Cross references
216 Possible Orthologues:

Matrix Metalloproteinase-14

Ensembl ID : ENSELUG00000003376
Gene Symbol: LOC105020567
3 Cross references
199 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSELUG00000000130
Gene Symbol: LOC105021572
3 Cross references
198 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSELUG00000004972
Gene Symbol: MTOR
1 Cross references
222 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSELUG00000010670
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSELUG00000015117
Gene Symbol: MC4R
2 Cross references
202 Possible Orthologues:

Melanocortin Receptor 3-Like

Ensembl ID : ENSELUG00000023970
Gene Symbol: LOC105022395
3 Cross references
139 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSELUG00000012826
Gene Symbol: LOC105022720
3 Cross references
153 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSELUG00000011751
Gene Symbol: MTNR1A
3 Cross references
138 Possible Orthologues:

Melatonin Receptor Type 1a-A

Ensembl ID : ENSELUG00000021302
Gene Symbol: LOC105022859
3 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).